ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,438Medicare Part D Prescriptions Filled, Including Refills

Rank: 287 out of 2094

$714K Total Retail Price of All Prescriptions

Rank: 233 out of 2094

261 Patients Receiving at Least One Drug in Part D
94%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

3% of this provider’s 8,046 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$85 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 339 318 1 1
DIOVAN HCT 333 333 2 28
NAMENDA 304 304 3 32
JANUVIA 278 258 4 35
DONEPEZIL HCL 261 261 5 20
AMLODIPINE BESYLATE 248 248 6 2
OMEPRAZOLE 221 212 7 4
LEVOTHYROXINE SODIUM 212 199 8 3
METOPROLOL SUCCINATE 174 174 9 9
CLOPIDOGREL 151 151 10 22
ATORVASTATIN CALCIUM 141 138 11 5
DIOVAN 132 131 12 13
EVISTA 129 126 13 131
EXELON 119 116 14 111
LACTULOSE 117 116 15 65
NEXIUM 109 93 16 16
ESCITALOPRAM OXALATE 109 109 16 46
METOPROLOL TARTRATE 105 105 18 10
GABAPENTIN 101 99 19 23
PLAVIX 99 99 20 38
METFORMIN HCL 96 83 21 8
JANUMET 92 69 22 86
ISOSORBIDE MONONITRATE ER 80 80 23 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 79 71 24 55
FLUTICASONE PROPIONATE 74 65 25 41
AMLODIPINE BESYLATE-BENAZEPRIL 72 69 26 58
DIVALPROEX SODIUM 71 71 27 69
LISINOPRIL 70 60 28 7
FUROSEMIDE 70 70 28 6
NABUMETONE 69 66 30 203
PAROXETINE HCL 69 57 30 77
CARVEDILOL 68 68 32 19
ADVAIR DISKUS 67 64 33 36
CRESTOR 65 65 34 15
LOSARTAN-HYDROCHLOROTHIAZIDE 62 62 35 52
CIPROFLOXACIN HCL 61 60 36 81
PROMETHAZINE HCL 58 45 R 37 184
SPIRIVA 57 57 38 60
SERTRALINE HCL 57 57 38 26
RANITIDINE HCL 55 45 40 80
LOSARTAN POTASSIUM 54 54 41 17
TORSEMIDE 54 51 41 118
ALLOPURINOL 54 54 41 50
LIPITOR 53 53 44 39
ZOLPIDEM TARTRATE 50 44 45 14
PANTOPRAZOLE SODIUM 50 50 45 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 15, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.